BRCA Support BC: Current & Future Directions for Research in BRCA

In this informative session, Dr. Intan Schrader will provide a look at the latest research and future developments in BRCA-related cancer care. As a leader in hereditary cancer research, Dr. Schrader will focus on what current studies mean for BRCA carriers, particularly in the areas of early detection and personalized treatment.

Dr. Schrader will discuss how new advancements in genetic testing, like long-read sequencing, are improving our ability to detect BRCA mutations and differentiate between hereditary and non-hereditary cancers. These advancements help in identifying cancer risks earlier and more accurately, leading to better prevention strategies and treatment options tailored to individuals.

The session will also highlight ongoing research efforts aimed at understanding how BRCA mutations affect cancer development and what this means for the future of cancer care. Dr. Schrader will explain how these studies are helping doctors develop new ways to detect cancer early and create more effective treatments specifically for people with BRCA mutations.